Limb-girdle Muscular Dystrophy Type 2A - 11 Studies Found
Recruiting |
: A Trial of PF-06252616 in Ambulatory Participants With LGMD2I : LGMD2I : 2016-07-12 : Drug: PF 06252616 |
Enrolling by invitation |
: Gene Transfer Clinical Trial for LGMD2D (Alpha-sarcoglycan Deficiency) Using scAAVrh74.tMCK.hSGCA : Limb Girdle Muscular Dystrophy Type 2D (LGMD2D) : 2013-07-24 : Drug: scAAVrh74.tMCK.hSGCA |
Completed |
: Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2I :
|
Completed |
: Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C :
|
Completed |
: Deflazacort in Dysferlinopathies :
|
Completed |
: Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D) : Muscular Dystrophies : 2007-06-27 :
|
Completed |
: MRI on Persons With Mutations in POMT2 Gene (LGMD2N) : Limb-girdle Muscular Dystrophy : 2016-04-27 |
Active, not recruiting |
: Clinical Outcome Study for Dysferlinopathy :
|
Recruiting |
: Congenital Muscle Disease Study of Patient and Family Reported Medical Information :
|
Completed |
: The Safety and Biological Activity of ATYR1940 in Patients With Limb Girdle or Facioscapulohumeral Muscular Dystrophies :
: 2015-09-28 :
|